Hansjakob Furrer Selected Research

Hansjakob Furrer Research Topics

Disease

34	Infections 01/2021 - 05/2002
22	Acquired Immunodeficiency Syndrome (AIDS) 10/2021 - 02/2002
18	HIV Infections (HIV Infection) 01/2016 - 03/2002
8	Coinfection 01/2019 - 07/2007
8	Opportunistic Infections (Opportunistic Infection) 01/2017 - 02/2002
7	Disease Progression 01/2022 - 07/2002
7	Tuberculosis (Tuberculoses) 09/2021 - 01/2007
7	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2021 - 08/2002
5	Pneumonia (Pneumonitis) 01/2022 - 10/2004
4	Viremia 01/2022 - 05/2003
4	Chronic Hepatitis C 10/2019 - 02/2005
4	Drug-Related Side Effects and Adverse Reactions 01/2017 - 01/2007
4	Hepatitis B 09/2016 - 07/2007
4	Neoplasms (Cancer) 10/2015 - 05/2008
4	Dyslipidemias (Dyslipidemia) 12/2009 - 05/2005
3	Myocardial Infarction 02/2021 - 06/2012
3	Kaposi Sarcoma (Kaposi's Sarcoma) 11/2018 - 05/2008
3	Hypersensitivity (Allergy) 09/2016 - 01/2008
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2015 - 01/2007
3	Hepatitis C 08/2014 - 01/2008
2	Bacterial Pneumonia 01/2022 - 04/2003
2	Stroke (Strokes) 02/2021 - 01/2017
2	Obesity 01/2021 - 07/2007
2	Yellow Fever 09/2020 - 01/2018
2	Abdominal Obesity 01/2020 - 06/2012
2	Cryptococcal Meningitis 01/2019 - 04/2015
2	Hypertension (High Blood Pressure) 04/2018 - 01/2017
2	Liver Diseases (Liver Disease) 09/2016 - 01/2014
2	Fibrosis (Cirrhosis) 09/2016 - 01/2014
2	Hodgkin Disease (Hodgkin's Disease) 04/2015 - 02/2015
2	Malaria 03/2015 - 06/2005
2	Lymphoma (Lymphomas) 02/2015 - 01/2008
2	Body Weight (Weight, Body) 04/2010 - 01/2005
2	Ulcerative Colitis 09/2007 - 01/2003
2	Hypertriglyceridemia 09/2007 - 05/2005
2	Diabetes Mellitus 07/2007 - 01/2007
2	Sexually Transmitted Diseases (Sexually Transmitted Disease) 11/2005 - 09/2004
1	Hemorrhage 02/2021
1	Inflammation (Inflammations) 02/2021
1	COVID-19 01/2021
1	Overweight 01/2021
1	Rheumatic Diseases (Rheumatism) 09/2020
1	Genetic Risk Score 01/2020
1	Prostatitis 01/2020
1	Osteoporosis 10/2019
1	Virus Diseases (Viral Diseases) 11/2018
1	Measles 11/2018

Drug/Important Bio-Agent (IBA)

17	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2004
16	Pharmaceutical PreparationsIBA 01/2022 - 10/2008
6	Tenofovir (Viread)FDA Link 10/2019 - 03/2006
6	Protease Inhibitors (Protease Inhibitor)IBA 04/2015 - 10/2005
5	LipidsIBA 01/2021 - 05/2005
5	Reverse Transcriptase InhibitorsIBA 10/2019 - 07/2007
5	NucleosidesIBA 10/2019 - 03/2007
4	AntigensIBA 01/2021 - 05/2008
4	AntibodiesIBA 01/2017 - 09/2004
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 02/2010
3	Interferon LambdaIBA 11/2018 - 04/2010
3	Ribavirin (Virazole)FDA LinkGeneric 11/2018 - 02/2005
3	Antiviral Agents (Antivirals)IBA 12/2016 - 06/2004
3	VaccinesIBA 01/2016 - 06/2005
3	Atazanavir Sulfate (Reyataz)FDA Link 09/2012 - 10/2005
3	Zidovudine (Retrovir)FDA LinkGeneric 04/2012 - 05/2002
2	ORALIT (ORS)IBA 01/2020 - 09/2007
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 09/2016
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2016 - 01/2014
2	Mefloquine (Lariam)FDA LinkGeneric 12/2015 - 03/2015
2	N-acetoacetyl-N-deacetylcolchicineIBA 04/2015 - 10/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2015 - 11/2005
2	Indinavir (Crixivan)FDA Link 01/2014 - 10/2005
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2014 - 04/2003
2	CholesterolIBA 06/2012 - 03/2007
2	HDL CholesterolIBA 06/2012 - 09/2007
2	Lamivudine (Epivir)FDA Link 04/2012 - 01/2010
2	Tuberculin (PPD)IBA 11/2011 - 01/2007
2	Ritonavir (Norvir)FDA Link 04/2010 - 05/2005
2	abacavir (Ziagen)FDA Link 09/2008 - 01/2008
2	Apolipoproteins E (ApoE)IBA 09/2007 - 05/2005
1	Mycobacterium tuberculosis antigensIBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 09/2020
1	Tigecycline (Tygacil)FDA Link 01/2020
1	Anti-HIV Agents (AIDS Drugs)IBA 01/2020
1	beta-lactamase CMY-2IBA 01/2020
1	tenofovir alafenamideIBA 10/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 11/2018
1	Rituximab (Mabthera)FDA Link 11/2018
1	Vitamin A (Retinol)FDA LinkGeneric 11/2018
1	elvitegravirIBA 01/2018
1	CobicistatIBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018

Therapy/Procedure

41	Therapeutics 01/2022 - 04/2002
27	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 02/2002
13	Art Therapy 01/2022 - 04/2002
3	Drug Therapy (Chemotherapy) 11/2018 - 06/2005
2	Critical Care (Surgical Intensive Care) 01/2021 - 10/2015
2	Retention in Care 01/2017 - 04/2015
2	Artificial Respiration (Mechanical Ventilation) 04/2015 - 11/2005
2	Chemoprevention 03/2015 - 06/2005
1	Cerebral Revascularization 02/2021